Alliance Global Partners analyst James Molloy upgraded BioCardia (BCDA) to Buy from Neutral with a $6 price target The company recently announced multiple clinical updates regarding its lead CardiAMP ...

Fintel reports that on January 27, 2025, Alliance Global Partners initiated coverage of Palladyne AI (NasdaqGM:PDYN) with a ...

Alliance Global Partners lowered the firm’s price target on Coda Octopus (CODA) to $10 from $11. The company’s Q4 results were underwhelming,” ...

Alliance Global Partners raised the firm’s price target on LiveOne (LVO) to $3 from $1.75 and keeps a Buy rating on the shares. On December 1, Tesla (TSLA) stopped paying for monthly digital ...

Alliance Global Partners assumed coverage on shares of Tamboran Resources (NYSE:TBN – Free Report) in a research note published on Tuesday, Ratings reports. The firm issued a buy rating and a $32.00 ...

Fintel reports that on December 18, 2024, Alliance Global Partners upgraded their outlook for Vitesse Energy (NYSE:VTS) from Neutral to Buy. As of December 4, 2024, the average one-year price ...

https://www.tipranks.com/news/the-fly/option-care-health-price-target-raised-to-35-from-30-at-jmp-securities Alliance Global Partners lowered the firm’s price ...

Alliance Global Partners analyst James Molloy upgraded BioCardia (BCDA) to Buy from Neutral with a $6 price target The company recently announced multiple clinical updates regarding its lead ...